-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DXpyGWTaK7Go/FomPR5XJFLjeCeoSvO8Q/DueFnBDv71S4kS7yde0hMuAeJiCT32 XlYgnH0Am2+WWLPIdNVXHA== 0001104659-04-041652.txt : 20050103 0001104659-04-041652.hdr.sgml : 20041231 20041230181132 ACCESSION NUMBER: 0001104659-04-041652 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041227 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20050103 DATE AS OF CHANGE: 20041230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ENPATH MEDICAL INC CENTRAL INDEX KEY: 0000833140 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411533300 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19467 FILM NUMBER: 041235109 BUSINESS ADDRESS: STREET 1: 15301 HGHWY 55 W CITY: PLYMOUTH STATE: MN ZIP: 55447 BUSINESS PHONE: 7635592613 FORMER COMPANY: FORMER CONFORMED NAME: MEDAMICUS INC DATE OF NAME CHANGE: 19960330 8-K 1 a04-15440_18k.htm 8-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 27, 2004

 

Enpath Medical, Inc.

(Exact name of registrant as specified in its charter)

 

Minnesota

(State or Other Jurisdiction of Incorporation)

 

0-19467

41-1533300

(Commission File Number)

(IRS Employer Identification No.)

 

 

15301 Highway 55 West

 

Plymouth, Minnesota

55447

(Address of Principal Executive Offices)

(Zip Code)

 

(763) 559-2613

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 


 

Section 1– Registrant’s Business and Operations

 

Item 1.01 – Entry into a Material Definitive Agreement

 

On December 27, 2004, Enpath Medical Inc. and Med-Design Corporation amended their Development and Licensing Agreement dated August 20, 2000, as amended September 7, 2001, for the Safety “Seldinger” Needle Device to eliminate the 2004 minimum purchase amount required to be made by Enpath to maintain its exclusivity under the Agreement.   Enpath also agreed to negotiate exclusively with Med-Design until April 30, 2005 for the potential sale of Enpath’s safety needle business to Med-Design in a manner that would provide uninterrupted supply of the safety needles to Enpath customers.   No arrangement to sell or purchase Enpath’s safety needle business will be binding on either Enpath and Med-Design, however, unless and until a definitive agreement, setting forth mutually acceptable terms, is executed by both parties.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

ENPATH MEDICAL, INC.

 

 

Dated: December 27, 2004

By:

 /s/ James D. Hartman

 

 

 

James D. Hartman

 

 

Chief Executive Officer

 

2

 -----END PRIVACY-ENHANCED MESSAGE-----